Reduced dorsal visual stream α2-adrenergic receptor availability is not associated with visuospatial impairment in Parkinson's disease.
Findings do not support a simple direct association between DVS α2-AR availability and visuospatial impairment in this cohort of patients with PD, and moderate evidence is provided for the absence of association.